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Abstract Lincosamides are a class of antibiotics used both
in clinical and veterinary practice for a wide range of
pathogens. This group of drugs inhibits the activity of the
bacterial ribosome by binding to the 23S RNA of the large
ribosomal subunit and blocking protein synthesis. Current-
ly, three X-ray structures of the ribosome in complex with
clindamycin are available in the Protein Data Bank, which
reveal that there are two distinct conformations of the
pyrrolidinyl propyl group of the bound clindamycin. In this
work, we used quantum mechanical methods to investigate
the probable conformations of clindamycin in order to
explain the two binding modes in the ribosomal 23S RNA.
We studied three lincosamide antibiotics: clindamycin,
lincomycin, and pirlimycin at the B3LYP level with the 6-
31G
** basis set. The focus of our work was to connect the
conformational landscape and electron densities of the two
clindamycin conformers found experimentally with their
physicochemical properties. For both functional conform-
ers, we applied natural bond orbital (NBO) analysis and the
atoms in molecules (AIM) theory, and calculated the NMR
parameters. Based on the results obtained, we were able to
show that the structure with the intramolecular hydrogen
bond C=O…H–O is the most stable conformer of clindamy-
cin. The charge transfer between the pyrrolidine-derivative
ring and the six-atom sugar (methylthiolincosamide), which
are linked via an amide bond, was found to be the dominant
factor influencing the high stability of this conformer.
Keywords Ribosome.Bacterial translation.
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Introduction
The three compounds lincomycin (a natural antibiotic
produced by Streptomyces lincolnensis and discovered in
1961), clindamycin, and pirlimycin (two semi-synthetic
derivatives of lincomycin) comprise a group of clinically
important antibiotics known as lincosamides.
The structure of lincomycin (Fig. 1a) can be divided into
two parts, a pyrrolidine derivative and a six-atom sugar ring
(methylthiolincosamide), which are linked via an amide
bond in the central part of the molecule. Clindamycin
(Fig. 1b) is obtained by 7(S)-chloro-substitution of the 7(R)-
hydroxyl group of lincomycin, and pirlimycin (Fig. 1c)i s
obtained by trimming the propyl group of clindamycin to
get an ethyl group. These compounds are soluble in water
and chemically stable both in the dry state and in solution.
Lincosamides block bacterial protein synthesis, which
takes place on the ribosomes. Ribosomes are organelles that
are composed of ribosomal RNAs (rRNA; ca. 65% by
mass) and proteins (ca. 35%) [1]. The bacterial 70S
ribosome can be separated into two subunits: large (50S)
and small (30S), named after their sedimentation coeffi-
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of 21 proteins and one 16S RNA chain, while the large
subunit contains over 30 proteins and two RNA chains
(23S RNA and 5S RNA). Lincosamides bind to the 23S
RNA (interacting with the A- and P-tRNA binding sites) of
the 50S ribosomal subunit and inhibit the peptidyltransferase
reaction, i.e., peptide bond formation [2]. Therefore, they
typically have a bacteriostatic mode of action.
The main spectrum of action of lincosamides includes
bacteria associated with skin infections, and lincosamides
are first-choice antibiotics used in veterinary dermatology.
However, although they do have adverse effects, such as
nausea, rash, or abdominal pain, lincomycin and clindamycin
are also effectively used in human medicine [3]. Clindamycin
shows stronger antibacterial activity than lincomycin. Linco-
samides are effective against Gram-positive bacteria, such as
Staphylococcus, Streptococcus, most anaerobic bacteria (e.g.,
Bacteroides fragilis), and some protozoa. In the latter case,
they can serve as an antimalarial drug. Gram-negative
bacteria are, in general, resistant to lincosamides, with one
important exception: Capnocytophaga canimorsus [4].
Lincosamides exhibit excellent pharmacokinetic proper-
ties; they are well absorbed orally and can penetrate well
into infected skin. Also, the minimum inhibitory concen-
tration (MIC90, the minimum concentration needed to
inhibit growth overnight in 90% of organisms) of clinda-
mycin towards Streptococcus pyogenes is over 120 times
lower than that of tetracycline [5]. Unfortunately, extensive
use of these antibiotics has led to increased resistance in
many strains of bacteria, which have been developing
various mechanisms to counter these drugs. One known
mechanism is structural modification of the drug’s target
(ribosome) through the methylation of 23S RNA (e.g., base
no. 2058 [6]) and/or mutations (e.g., of bases G2057,
A2058, A2059, C2452, and C2611 [7]). Other mechanisms
of resistance are active efflux of the drug across the cell
surface, or its enzymatic deactivation [8]. Bacterial resistance
together with side effects are the most important reasons for
improving known lincosamides and designing modified
compounds.
The conformational properties of free clindamycin and
lincomycin have been studied using X-ray techniques [9,
10]a sw e l la s
1Ha n d
13C NMR spectroscopy and
molecular dynamics [11]. However, Verdier et al. [11] also
investigated lincosamide–ribosome interactions by two-
dimensional transferred nuclear Overhauser effect spectros-
copy (TRNOESY), and showed that the conformation of
the lincosamide plays a crucial role in its binding to the
ribosome. Ravikumar et al. [9] reported the crystal
structures of clindamycin hydrochloride monohydrate and
its ethanol solvate. They found that the free conformers of
clindamycin and LinB (lincosamide nucleotidyltransferase)
enzyme-bound clindamycin are similar [12]. Rajeswaran et
al. [10] solved the X-ray structure of lincomycin hydro-
chloride and found that intra- and intermolecular hydrogen
bonds stabilize the structure of the drug. On the other hand,
pirlimycin has not been subjected to extensive theoretical
studies.
There are four crystallographically resolved structures of
clindamycin bound to a target: three in complex with the
ribosome [13–15], and one with the LinB molecule [12],
the bacterial enzyme responsible for the inactivation of
lincosamides by nucleotidylation. Their crystal structures as
well as the structure of the native ribosome [16] are
available through the Protein Data Bank (PDB). These
crystallographic data form the basis for our theoretical
studies of chemical and physical properties of lincosamides.
Two out of the three conformers of clindamycin, when
bound to the ribosome, show significant differences
between antibiotic conformations: in two structures, the
pyrrolidynyl propyl group is rotated by 180° relative to the
other conformer. Clindamycin shows intramolecular hydrogen
bonds that stabilize the respective conformations.
Theoretical calculations provide a complementary way
to study molecular systems containing an intramolecular
hydrogen bond (IHB). Although the accuracy of ab initio
Fig. 1 Chemical structures of
lincosamides: lincomycin
(natural antibiotic, a) and
its semi-synthetic derivatives
clindamycin (b) and
pirlimycin (c)
2728 J Mol Model (2012) 18:2727–2740calculations is still below the state-of-art accuracy of
experimental spectroscopic data, these calculations provide
information about the shape of the potential energy surface
(PES) without the need for any initial assumptions.
Characterizing the conformational changes and their possible
effects on the encounter with and binding to the ribosome are
important aspects of understanding the mechanism of action
of lincosamides. To the best of our knowledge, no systematic
and accurate study of the conformational behavior of
clindamycin in the gas phase and in solution has been
reported. The aim of the work described in the present paper
was to clarify the role of intramolecular hydrogen bonds in
clindamycin using quantum chemical calculations. These ab
initio calculations consist of the following steps: the choosing
the model structures, geometry optimization, natural bond
orbital analysis (NBO), atoms in molecules analysis (AIM),
and spectroscopic NMR parameter calculations, which
are currently among the most popular methods used for
conformational analysis.
The methods applied in the calculations are described in
the first section of the paper. We then characterize the
conformations and molecular properties, focusing on the
intramolecular hydrogen bonds. The paper concludes with a
summary.
Computational details
The first step was to prepare models of the antibiotics. Four
structures of clindamycin are available in the Protein Data
Bank [17] (as of May 2011). Three of these structures are in
complex with the bacterial ribosome [13–15], while one is
in complex with LinB [12]. The two ribosome-complexed
structures show similar clindamycin conformers, and in one
the pyrrolidynyl propyl group is rotated by 180°. In this
work, we used two significantly different conformers of
clindamycin, which were taken from ribosome–clindamycin
complexes of Deinococcus radiodurans [13]( P D Bc o d e
1JZX) and Haloarcula marismortui [14]( P D Bc o d e1 Y J N ) .
The experimental structures of lincomycin and pirlimycin are
not available. Therefore, based on the known X-ray
structures of clindamycin (Fig. 2), we built two analogical
conformers of both lincosamides.
The second step involved optimizing the geometries of
all of the antibiotic models constructed, using density
functional theory (DFT) at the B3LYP level [18, 19] with
the 6-31G
** basis set and a redundant coordinate algorithm
[20].
We considered two cases for the optimization procedure.
In the first case, we optimized the investigated molecules
Fig. 2 Ball and stick representation showing the superposition of two clindamycin conformers when bound to the ribosome. Black conformer A,
gray conformer B (only heavy atoms are shown for clarity)
J Mol Model (2012) 18:2727–2740 2729without any constraints. In the second case, the two
dihedral angles d(C15–C16–N2–C19) and d(C16–N2–
C19–C20), which are significantly different in both
experimentally known conformers (A and B; see Fig. 2),
were kept constant in the optimization procedure to
differentiate between the two conformers. The values of
the dihedral angles d(C15–C16–N2–C19) and d(C16–N2–
C19–C20) for conformer A were set to −47° and −180°,
while they were set to 119° and 178°, respectively, for
conformer B, in accordance with known experimental
results. Thus, we obtained two conformations that are
minima on the PES. The corresponding frequency calcu-
lations were carried out at the same level in order to
confirm the nature of the stationary points. No imaginary
frequencies were observed, which means that the structures
of the antibiotics are true minima. These structures, which
we called “exp-opt,” were used during AIM, NBO, and
NMR calculations (see below).
In a third step, in order to explore the conformational
landscape of the molecules, we performed a potential energy
surface scan along the torsional coordinates mentioned above
in a relaxed manner (i.e., all other geometrical parameters
were optimized at each point) for both conformers. The scan
was calculated using the B3LYP/6-31G
** method.
Most spectroscopic measurements are performed on
liquid samples. To describe the environment of the
antibiotic, either the continuum solvation model or an
atomic representation of the solvent can be used. Therefore,
as a fourth step, in order to study the solvent effect,
optimization and frequency calculations were also performed
at the B3LYP/6-31G
** level of theory in combination with
the polarizable continuum solvent model based on the
integral equation formalism (IEF-PCM) [21]. In this model,
the solvent is described by a dielectric constant, which was
set to 80 in our work. The second model that was used to
describe the environment of the antibiotic, and mimics the
surroundings of the antibiotic in the ribosomal RNA, was the
model with point ions placed around the antibiotic [22, 23].
The positions of these point charges were obtained from the
X-ray structures of the ribosome–clindamycin complexes
[13, 14]. The coordinates of residues within 10 Å of each
clindamycin atom were considered, and partial charges were
assigned based on the G43b1 GROMOS96 force field [24].
In this way, we studied the effect of the charged ribosome
environment on the conformations of the lincosamides.
Next, in order to gain a deeper insight into the nature of
the conformational changes, NBO and AIM electron
density analyses were applied for the two analyzed con-
formers of clindamycin. The bond critical points (BCPs) were
characterized in terms of electron density and their Laplacian
values. These gas-phase calculations were performed at the
B3LYP/6-31G
** level.
NMR spectroscopy is one of the techniques used to
investigate molecular structures and interactions. In the last
Table 1 Total energies (E0, in au), zero-point energies (ZPE, in kcal/
mol), and relative Gibbs free energies at 298.15 K (ΔG, in kcal/mol).
Top: values for the fully optimized A and B conformers of
clindamycin, lincomycin, and pirlimycin in vacuum. Bottom: values
for the A and B conformers of clindamycin, lincomycin, and
pirlimycin (optimized using a redundant coordinate algorithm in
vacuum) in the PCM model of solvent and in the point ions. Two
dihedrals were kept constant, d(C15–C16–N2–C19)=−47.0 and d
(C16–N2–C19–C20) =−180.0 for conformer A, and d(C15–C16–N2–
C19)=119.0 and d(C16–N2–C19–C20)=178.0 for conformer B. All
calculations were performed at the B3LYP/6-31G
** level
Clindamycin Lincomycin Pirlimycin
ABABAB
Fully optimized structures
E0 −2049.831737 −2049.846556 −1665.458409 −1665.463660 −2010.515225 −2010.54063381
ZPE 323.26 323.66 332.14 332.40 305.59 305.85
ΔG 8.20 0.0 2.41 0.0 15.69 0.0
Structures with frozen dihedrals C15–C16–N2–C19 and C16–N2–C19–C20
E0 −2049.831704 −2049.844535 −1665.456720 −1665.455960 −2010.514391 −2010.455988
ZPE 323.29 323.53 332.19 331.99 305.35 305.37
ΔG 8.05 0.0 0.23 0.0 5.32 0.0
E0
PCM −2049.796886 −2049.804378 −1665.418265 −1665.419456 −2010.441623 −2010.460224
ZPE
PCM 323.87 324.10 332.77 332.56 305.92 305.94
ΔG
PCM 6.58 0.0 0.43 0.0 5.40 0.0
E0
ions −2048.43909665 −2048.44804200 −1664.05485157 −1664.05656314 −2009.11644087 −2009.12370514
ZPE
ions 329.99 329.71 339.94 339.56 312.95 312.74
ΔG
ions 5.55 0.0 1.07 0.0 3.86 0.0
2730 J Mol Model (2012) 18:2727–2740part of our work, we calculated the NMR chemical shifts
and spin–spin coupling constants for the gas-phase opti-
mized geometries at the B3LYP/6-31G
** level. Shielding
constants were calculated using the B3LYP/aug-pcS-1 [25]
method and the GIAO routine [26–30]. The chemical shifts
of the i-th nuclei were calculated as dðiÞ¼siðXÞ siðCÞ;
where σi(C) and σi(X) are the isotropic parts of the
shielding tensors of the i-th nuclei in clindamycin and the
i-th nuclei in the reference X molecule, respectively. The
spin–spin coupling constants were calculated at the B3LYP/
aug-pcJ-0 [31, 32] level. The nonstandard basis sets were
taken from the EMSL Basis Set Library [33, 34].
All of the calculations were carried out using the
GAUSSIAN03 and GAUSSIAN09 software packages
[35]. The NBO calculations were performed with the
NBO 5.0 program [36], while AIM calculations were
performed using AIM2000 [37]. Data were analyzed using
Gabedit [38], and the visualizations were carried out with
VMD [39] and XDrawChem.
Results and discussion
Conformational analysis
The energies, the zero-point vibrational energies (ZPE), and
the Gibbs free energy (ΔG) values based on the harmonic
field relative to the most stable one at 298.15 K calculated
in the gas phase, taking solvent effects into account, are
depicted in Table 1. The selected geometric parameters
obtained from gas-phase calculations for both conformers
of clindamycin, lincomycin, and pirlimycin in their bound
modes are given in Table 2. Their structures and atom
numbering schemes are presented in Fig. 3.
Table 2 Selected geometric
parameters (in Å and degrees)
for the “exp-opt” structures of
both conformers (A and B) of
clindamycin, lincomycin, and
pirlimycin calculated at the
B3LYP/6-31G
** level in
vacuum
Clindamycin Lincomycin Pirlimycin
AB AB AB
r(S1–C11) 1.855 1.857 1.850 1.852 1.854 1.857
r(C12–O4) 1.422 1.415 1.421 1.413 1.422 1.414
r(C12–C13) 1.526 1.536 1.421 1.537 1.527 1.536
r(C13–O5) 1.426 1.412 1.425 1.412 1.426 1.412
r(C15–O7) 1.443 1.432 1.451 1.438 1.441 1.430
r(O7–C11) 1.412 1.416 1.418 1.820 1.413 1.415
r(C15–C16) 1.543 1.545 1.549 1.544 1.542 1.538
r(C16–C17) 1.543 1.536 1.558 1.555 1.542 1.538
r(C17–O8) –– 1.427 1.419 ––
r(C17–Cl28) 1.833 1.852 –– 1.832 1.852
r(C17–C18) 1.523 1.521 1.525 1.526 1.524 1.520
r(C16–N2) 1.462 1.457 1.466 1.462 1.462 1.456
r(N2–C19) 1.371 1.362 1.365 1.370 1.372 1.369
r(C19–O9) 1.223 1.232 1.229 1.230 1.222 1.231
r(C19–C20) 1.542 1.533 1.542 1.537 1.541 1.536
r(C20–N3) 1.462 1.452 1.482 1.457 1.460 1.458
r(N3–C21) 1.450 1.451 1.450 1.454 1.450 1.454
r(N3–C22) 1.459 1.459 1.465 1.459 1.458 1.459
r(C22–C23) 1.537 1.537 1.531 1.533 1.538 1.532
r(C23–C24) 1.557 1.557 1.542 1.552 1.559 1.551
r(C24–C20) 1.548 1.558 1.542 1.561 1.548 1.561
a(C20–C19–N2) 113.8 114.5 –– ––
a(C19–N2–C16) 128.6 124.2 –– ––
a(N2–C16–C15) 113.8 112.2 –– ––
a(N2–C16–C17) 113.0 110.8 –– ––
a(C16–C17–C18) 113.2 113.9 –– ––
a(C16–C15–C14) 111.9 123.0 –– ––
a(O9–C19–N2) 124.4 123.0 –– ––
d(C15–C16–N2–C19) −47.0 119.0 −47.0 119.0 −47.0 119.0
d(C16–N2–C19–C20) −180.0 178.0 −180.0 178.0 −180.0 178.0
J Mol Model (2012) 18:2727–2740 2731Fig. 3 Ball and stick models of
the studied molecules and their
atom numbering schemes.
Top: clindamycin, middle:
lincomycin, bottom: pirlimycin
2732 J Mol Model (2012) 18:2727–2740A number of factors influence the structure and stability
of the conformers of clindamycin. Our results show that the
most important is the energy profit from the formation of
the IHB. The presence of hydrogen-bond donors (O–H, N–H,
C–H) and hydrogen-bond acceptors (C=O, Cl) allows for a
range of hydrogen-bond combinations and a number of stable
forms [40, 41]. Let us now concentrate on the C19–O9…
H37–O6 IHB. Because of the internal hydrogen bonds, one
conformer is stabilized to a greater extent than the others.
First and foremost, at the B3LYP/6-31G
** level, the most
stable clindamycin B conformer is more energetically
favored than the next most stable by as much as 8.0 kcal/
mol. The energetic picture significantly changes for linco-
mycin and pirlimycin. In the case of lincomycin, no single
conformer is favored at 298.15 K, while the A conformer of
pirlimycin is more stable than B according to the three
models used: vacuum, PCM, and point ions. The clindamycin
B conformer in vacuum displays both the longest O6–H37
bond (0.980 Å) and the shortest IHB distance, r(C19–O9…
H37–O6)=1.819Å. The r(C19–O9…H39–C15) IHB dis-
tance in the less stable A conformer is 2.370 Å, and r(C15–
H39)=0.970 Å is the most important component of the
Fig. 4 Changes in the energy
(in au) of the C15–C16–N2–
C19 dihedral angle in both
clindamycin conformers, A (top)
and B (bottom) in vacuum;
calculations were performed
with the B3LYP/6-31G
**
method
J Mol Model (2012) 18:2727–2740 2733conformer’s stability. The differences in the geometries of
the two clindamycin conformers are related almost exclu-
sively to the IHBs in the central part of the molecule. For the
most stable conformer, B, an eight-atom ring is formed,
whereas a six-atom ring is found in the A conformer.
Potential energy scans for internal rotation around the C–N
single bond were obtained by allowing the C15–C16–N2–
C19 dihedral angle to vary from 0 to 180° for clindamycin in
vacuum and an aqueous PCM phase. The values of the
startingdihedrals weredifferentinthe A and B conformers, as
shown in Fig. 2. Full geometry optimizations at a fixed
dihedral angle with an increment of 10° were carried out.
The graphs of potential energy as a function of the dihedral
angle for gas-phase calculations are shown in Fig. 4.T o
estimate the influence of its surroundings on the
conformation of clindamycin, both conformers that are
stable in the gas phase were analyzed using the IEF-
PCM/B3LYP/6-31G
** method. Table 1 confirms that
solvation has a relatively small effect on the energy
difference between conformers. The B conformer of
clindamycin is favored over the A conformer by 6.6 and
5.6 kcal/mol according to the PCM and point-ion models,
respectively.
Natural bond analysis
In general, the differences in the conformations of the two
models of clindamycin can be understood qualitatively in
terms of changes in bond lengths, angles, and the electron
density distribution over the whole structure. Natural
population analysis [42] is recognized as a reliable tool to
rationalize different trends observed in molecules containing
IHB. In this section, we will discuss the results of NBO
calculations.
Analysis of the Mülliken charges for the heavy atoms
(data not shown) suggests relationships between the charges
and geometrical parameters of the two conformers. The ring
with IHB in the B conformer of clindamycin consists of one
nitrogen (N2) atom with a charge of −0.53 au, two oxygen
atoms (O9 and O6) with charges of −0.54 au and −0.59 au,
and carbon atoms with charges ranging from 0.60 au to
0.02 au. In the A conformer of clindamycin, the negative
charges of both oxygens are slightly decreased, while both
carbon atoms become more positive (0.61 au, 0.07 au).
Such a decrease in negative charge with the changes in
Fig. 5 Representations of
hyperconjugative intramolecular
interactions, based on the NBO
analysis of both clindamycin
“exp-opt” conformers: red
dashed line for A (left), blue
dashed line for B (right);
B3LYP/6-31G
** in vacuum
Table 3 Selected second-order perturbation energy (ΔE
2,i nk c a l / m o l )
between donor and acceptor orbitals and charge transfer (Δqi.j,i na u )i n
the A (top) and B (bottom) conformers of clindamycin. Calculations
were performed for “exp-opt” structures at the B3LYP/6-31G
** level in
vacuum
NBOdonor (i) NBOacceptor ( j) ΔE
2 (kcal/mol) Δqi.j (au)
A
LPN2 σ
∗C19−O9 57.27 0.118
LPN3 σ
∗C22−H45 7.89 0.068
LPN3 σ
∗C20−H50 7.73 0.066
LPN3 σ
∗C21−H48 8.31 0.069
LPO4 σ
∗C12−C11 8.52 0.068
LPO6 σ
∗C14−C13 4.32 0.048
LPO6 σ
∗C14−H37 7.11 0.066
LPO9 RY
∗C19 16.51 0.142
LPO9 σ
∗C20−C19 20.86 0.103
LPO9 σ
∗C19−N2 26.11 0.124
LPO9 σ
∗C15−H39 0.93 0.024
B
LPN2 σ
∗C19−O9 60.17 0.119
LPO5 σ
∗C13−C12 9.21 0.069
LPO6 σ
∗C15−C14 9.07 0.070
LPO9 RY
∗C19 14.25 0.132
LPO9 σ
∗C20−C19 21.04 0.106
LPO9 σ
∗C19−N2 20.38 0.112
LPO9 σ
∗O6−H37 8.60 0.074
2734 J Mol Model (2012) 18:2727–2740torsional angles that occur when moving from the B to the
A conformer is related to the fractional transfer of the
charge to electronegative oxygen atoms in the B conformer
of clindamycin.
The second-order perturbation energy (ΔE
2) due to the
interaction energy between the donor and acceptor orbitals
in the central part of the molecule together with the charge
transfer (CT) between two moieties of the molecule are
Fig. 6 Molecular graphs of both “exp-opt” conformers of clindamy-
cin (top:A ,bottom: B) based on critical points obtained from the AIM
analysis. The brown, red, blue, yellow, purple, and silver beads
represent C, O, N, S, Cl, and H atoms, respectively. The light violet
and light green beads represent the (3, +1) and (3, −1) critical points,
respectively. The H-bonds [paths connecting the (3, −1) critical points]
are marked with dashed lines
J Mol Model (2012) 18:2727–2740 2735presented in Table 3. The selected orbital interactions (with
a stabilizing effect of over 8 kcal/mol) are presented in
Fig. 5 for both clindamycin conformers.
Considering that the charge transfer accompanies the
formation of IHB in the NBO model, the donor–acceptor
interaction energies ΔE
2 can be taken as a measure of the
strength of the intramolecular interaction. In the case of the
central H45–N2–C19–O9 group, the CT from the lone pair
orbital on N2 is mainly directed to the antibonding σ
∗
C19–O9
orbital (0.118 in the A conformer and 0.119 au in the B
conformer). Other important charge-transfer stabilizations are
observed between the lone pair orbital of O9 and the
antibonding σ
∗
C20–C19 orbital (0.103 for the A conformer
and 0.106 au for the B conformer), as well as between the
lone pair of the O9 orbital and the antibonding σ
∗
C19–N2
orbital (0.124 for the A conformer and 0.112 au for the B
conformer). Additionally, for the A conformer, we found
quite a strong interaction between the lone pair orbital on O4
and the antibonding σ
∗
C12–C11 orbital (0.068 au). Similar
interactions were also seen for the B conformer. The lone
pair orbital on O6 interacts with the antibonding σ
*
C15–C14
one (0.070 au), and the lone pair orbital on O5 with the
antibonding orbital σ
∗
C13–C12 (0.069 au). On the other hand,
the CT that occurs from the lone pair orbital on O9 through
the IHB to the antibonding σ
∗
H39–C15 orbital (0.024 au) for
the A conformer is lower than that for the σ
*
H37–O6 orbital of
the B conformer (0.074 au). To summarize, NBO analysis
indicates that the occupancy of the antibonding σ
*
C15–H39
orbital in the A conformer or the σ
*
O6–H37 orbital of the
eight-member moiety in the B conformer should be an
overall indicator of conformational stability. Therefore,
the charge transfer between the pyrrolidine-derivative
ring and the six-atom sugar (methylthiolincosamide),
which are linked via an amide bond, is the dominant
factor in the greater stability of the B conformer.
Atoms in Molecules analysis
Theabsenceorpresenceofmanytypesofhydrogenbondscan
influence the energy properties of molecular conformers. In
many cases, the Atoms in Molecules (AIM) method is a
practical tool for understanding the properties of hydrogen
bonds. It identifies a unique line of communication between
two nuclei, and provides a point describing the nature of this
interaction. Topological analysis of the electron density
distribution provides evidence for bonding interactions
through the discovery of a (3, −1) critical point (ρBCP), which
is a key topological descriptor of internuclear interactions,
while the Laplacian of the electron density values at the
critical point ∇
2ρBCP is another sensitive measure of the
Table 4 The lengths of H-
bonds and the electron density
and Laplacian values for
selected critical points of
the A (top) and B (bottom)
clindamycin “exp-opt”
conformers optimized at
the B3LYP/6-31G
** level
in vacuum
Critical point no. Atom numbers and names dHB ρCP ∇
2ρCP
A
Rings
CP1 N3–C20–C22–C23–C24 – 0.0381 −0.0689
CP2 O7–C11–C12–C13–C14–C15 – 0.0185 −0.0301
CP3 O5–H37–O6–C13–C14 – 0.0191 −0.0250
CP4 O7–C15–C16–C17–H41 – 0.0026 −0.0027
H-bonds
CP5 C15–O7…H41–C17 2.322 0.0155 −0.0164
CP6 C19–O9…H39–C15 2.370 0.0146 −0.0131
CP7 C17–Cl28…H29–C10 2.982 0.0055 −0.0044
CP8 C13–O5…H37–O6 2.147 0.0195 −0.0194
B
Rings
CP1 N3–C20–C22–C23–C24 – 0.0380 −0.0678
CP2 O7–C11–C12–C13–C14–C15 – 0.0027 −0.0023
CP3 O5–H35–O6–C14–C13 – 0.0271 −0.0285
CP4 O7–C15–C16–C17–H41 – 0.0212 −0.0027
CP5 O6–H37–O9–C19–N2–C16–C15–C14 – 0.0091 −0.0105
H-bonds
CP6 C15–O7…H41–C17 2.320 0.0154 −0.0162
CP7 C14–O6…H35–O5 2.102 0.0222 −0.0203
CP8 C19–O9…H37–O6 1.819 0.0340 −0.0248
CP9 C17–Cl28…H30–C10 3.000 0.0053 −0.0043
2736 J Mol Model (2012) 18:2727–2740properties of a classical bond. It should be noted that there is
some controversy regarding the use of AIM as a diagnostic
tool for bonding interactions [43]. However, typical inter-
molecular as well as intramolecular H-bonds can be
categorized properly, as has been proven in the literature
[44, 45].
The Popelier criteria [44, 46] for hydrogen-bond
formation include the requirement that ρBCP is in the range
0.002–0.040 au, and the need for the value of the Laplacian
at the hydrogen-bond critical point ∇
2ρBCP to be between
0.02 and 0.15 au. It is not, however, always necessary to
fulfill these criteria [47]. A negative Laplacian reveals
excess potential energy at the BCP, meaning that the
electronic charge is concentrated into a bond. A positive
∇
2ρBCP reflects an excess of kinetic energy in a bond,
indicating a local depletion of the electron density along a
bond path. In other words, generally, the Laplacian of ρ is
positive when ρ is locally reduced, and negative if it is
locally concentrated.
According to criteria elaborated by the AIM theory, we
found two types of intramolecular H-bonds in clindamycin:
typical hydrogen bonds of type CH…OC in the A
Fig. 7 The electron density ρCP
(top) and the Laplacian ∇
2ρCP
(bottom) as functions of intra-
molecular hydrogen-bond
length in both conformers of
clindamycin
J Mol Model (2012) 18:2727–2740 2737conformer and OH…O=C in the B conformer, and
unconventional H-bonds of type OH…X (X=O, Cl) in
both conformers (Fig. 6). The numerical values for the
electron density (ρBCP) and Laplacian (∇
2ρBCP) are pre-
sented in Table 4. Figure 7 shows plots of ρBCP (top) and
∇
2ρBCP (bottom) versus the length of the hydrogen bond
rO...H. The general shape of the ρBCP curve is that of an
exponential decay, as expected (see Fig. 7). The linear
correlation between ∇
2ρBCP and rO...H illustrates (Fig. 7)
that, in accordance with chemical intuition, ρO...H is
increased in an IHB.
The electron density at the critical points is equal to
0.034 au for the B conformer (BCP8) and 0.014 au for
the A conformer (BCP6), which is in line with the most
stable B structure. ∇
2ρBCP, the second measure of the
bond properties according to AIM, is barely below zero,
and remains ca. −0.02 in the B conformer and −0.013 au
in the A conformer, which could indicate weak hydrogen-
bonding regions. However, for the IHBs found in this
work, the Laplacian at the bond critical point tends to be
negative (although small), and smaller than that for an
intermolecular hydrogen bond, suggesting that the thresh-
old for this descriptor should be revised. This analysis
indicates that the main influence on the stability of the B
conformer is the IHB between the two moieties of the
molecule.
NMR chemical shifts
The experimental
13C NMR chemical shifts of clindamycin
fall within the interval 16–90 pm [11]. The B3LYP/aug-
pcS-1 values are shown in Table 5. The calculated values
for the
13C chemical shifts are in fairly good agreement
with the experimental data. As chemical shifts are sensitive
to subtle changes in the electronic structure, which depends
in a rather complex manner on the molecular structure, we
will now discuss the dependence of the calculated NMR
chemical shifts on the conformation and the IHB. As usual,
the central part of the molecule is the most interesting part
to consider for this purpose. The chemical shifts of the
carbon atoms are predicted to be located in their usual
ranges: δ(
13C=O) near to 185 ppm, δ(
13C–H) close to
70 ppm. δ(
13C=O) exhibits a sensitivity to IHB: the highest
value (188.6 ppm) occurs for the B conformer of
clindamycin, which is stabilized by the C19–O9…H37–
O6 intramolecular hydrogen bond more than the A
conformer (185.1 ppm) is stabilized by the C19–O9…
H37–O6 bond. The δ(
15N) chemical shifts vary from −350
to ca. −280 ppm. These chemical shifts have also been
shown to depend strongly on the local properties of the
electron density. The small absolute value of the chemical
shift of N2 in the B conformer is in line with the small
absolute value of the charge density on this nucleus (−0.547
in the A conformer and −0.530 in the B conformer). Finally,
it is clear that δ(
17O) can be classified into two groups. In the
first group, the oxygen acts as the roton acceptor for the OH
group, and its chemical shift is lower for the B conformer
than for the A conformer of clindamycin. The chemical shift
of the hydroxyl oxygen O6 is the highest for the A
conformer (considering its absolute value), and the same is
true of the oxygen O7 in the ring.
The calculated oxygen chemical shifts correlate with the
charges, but they are of limited diagnostic value due to the
large line widths in the oxygen NMR spectra.
Finally, let us now focus on the conformational
sensitivities of individual spin–spin coupling constants
(SSCC). The selected intramolecular SSCCs are gathered
in Fig. 8. Some coupling constants vary with changes in
Table 5 B3LYP/aug-pcS-1 calculated chemical shifts for both
clindamycin “exp-opt” conformers optimized at the B3LYP/6-31G
**
level in vacuum. We used
1H (TMS)=31.50,
13C (TMS)=182.20,
15N
(CH3NO2)=167.89,
17O (CH3NO2)=−389.95 (+605),
33S (CS2)=
1131.94, and
35Cl (NaCl)=151.02 as references
Atom Chemical shifts (ppm) Experimental value [11]
AB
S1 −350.15 −342.59 –
N2 −293.38 −285.97 –
N3 −347.65 −349.95 –
O4 63.47 51.98 –
O5 72.56 65.78 –
O6 85.97 72.67 –
O7 34.21 32.74 –
O9 295.05 260.14 –
C10 19.7 20.9 15.5
C11 98.74 104.44 90.0
C12 77.66 79.92 70.5
C13 76.95 77.63 73.2
C14 73.11 76.87 70.9
C15 72.95 78.14 71.8
C16 65.72 62.1 55.8
C17 71.13 77.03 60.7
C18 25.17 26.44 24.5
C19 185.06 188.59 172.4
C20 78.9 78.62 71.1
C21 43.24 43.48 43.4
C22 71.04 70.74 64.3
C23 43.05 46.37 39.3
C24 41.47 44.96 38.7
C25 43.59 44.53 37.0
C26 27.96 29.75 23.3
C27 17.6 18.89 16.0
Cl28 341.29 336.87 –
2738 J Mol Model (2012) 18:2727–2740conformation; for example
1JC15−C16 changes from 5.1 to
5.7 Hz when moving from the A to the B conformer.
However, more interesting is the
1JH37−O9 SSCC transmit-
ted through the C=O…H–O IHB, which is equal to 5.3 Hz
in the B conformer. This value is large enough to be
measured experimentally.
Conclusions
We have quantum chemically characterized the two con-
formers of each of the known lincosamides clindamycin,
lincomycin, and pirlimycin at the B3LYP/6-31G
** level.
Internal rotations in clindamycin were investigated in vacuum
Fig. 8 The selected B3LYP/aug-pcJ-0 calculated spin–spin constants J (in Hz) for both “exp-opt” conformers of clindamycin, i.e., A (top) and B
(bottom), optimized at the B3LYP/6-31G
** level in vacuum
J Mol Model (2012) 18:2727–2740 2739and within the framework of the IEF-PCM model [21]. Using
NBO analysis, and with the aid of the AIM theory, we have
characterized the intramolecular hydrogen bonds in these
molecules. We focused on the sensitivities of electronic
structure parameters such as NBO atomic charges, bond
critical points, NMR chemical shifts, and spin–spin coupling
constants to the conformation of clindamycin.
The two most stable conformers of clindamycin exhibit
C=O···H–O intramolecular hydrogen bonds. According to
NBO and AIM analyses, the presence of this internal
hydrogen bond between the pyrrolidine-derivative ring and
the six-atom sugar (methylthiolincosamide) is the main
influence on conformer stability in vacuum and in water.
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